1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity >99.0% (HPLC)

Incazelo emfushane:

Igama: 1-(2,3-Dichlorophenyl)piperazine Hydrochloride

Omqondofana: 2,3-DCPP HCl

I-CAS: 119532-26-2

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Impushana Emhlophe noma Engamhlophe

I-Intermediate ye-Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali I-1-(2,3-Dichlorophenyl) i-piperazine Hydrochloride
Omqondofana 2,3-DCPP HCl;1-(2,3-Dichlorophenyl) piperazine HCl;I-Aripiprazole EP Ukungcola B;I-Aripiprazole Inhlanganisela Ehlobene C
Inombolo ye-CAS 119532-26-2
Inombolo yeCAT I-RF-PI2268
Isimo Sesitoko Esitokweni, Amandla Okukhiqiza 30 MT/Inyanga
I-Molecular Formula C10H12Cl2N2·HCl
Isisindo samangqamuzana 267.58
I-Melting Point 245.0~247.0℃
Isitoreji Nokuzwela I-Hygroscopic.Amazinga okushisa e-ambient
Ukuncibilika Emanzini Incibilika Emanzini
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe noma Engamhlophe
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
Ukulahlekelwa Ekumisweni <0.50%
Izinsalela ekushiseni <0.10%
Ukungcola Okukodwa <0.50%
Ukungcola Okuphelele <1.00%
Izinsimbi Ezisindayo (njenge-Pb) ≤20ppm
I-Infrared Spectrum Ivumelana Nesakhiwo
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Aripiprazole (CAS: 129722-12-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:I-Hygroscopic.Gcina kude namanzi/umswakama kanye nama-oxidizing agents.Gcina isitsha sivalwe ngokuqinile bese usibeka endaweni epholile, eyomile futhi engenawo umoya.Gcina ngaphansi kwegesi engasebenzi

Izinzuzo:

1

I-FAQ:

Isicelo:

I-1-(2,3-Dichlorophenyl) i-piperazine Hydrochloride (i-CAS: 119532-26-2) iyingxenye ebalulekile ye-Aripiprazole (CAS: 129722-12-9).I-Aripiprazole iwuhlobo olusha lokuphuma kokuphuma kwe-quinoline e-lipid encibilika kakhulu, isici sayo sezemithi ukuthi akuyona nje i-postsynaptic dopamine D 2 receptor antagonist, kodwa futhi i-presynaptic dopamine D 2 receptor agonist, ingaphinde ijabulise u-D 1, D 3, D 4 ama-receptors;inomphumela okabili wokwenza kusebenze ingxenye noma ukuphikisa kwesamukeli ku-5-HT 1A isamukeli;inesenzo esiphikisana ngokuphelele nesamukeli se-5-HT 2A.Lesi sici sihlukile kunesesizukulwane sokuqala, kanye nama-antipsychotic atypical ayingxenye yezidakamizwa ze-antipsychotic zesizukulwane sesibili, ngakho-ke sibizwa ngokuthi i-dopamine system stabilizer noma i-antipsychotic yesizukulwane sesithathu.Njengoba ithengiswa emakethe, isetshenziswa kakhulu ku-schizophrenia yomtholampilo, ekwelapheni ukuphazamiseka okuthintayo nezinye izifo zengqondo.Ngokusho kwezincwadi, i-aripiprazole inemiphumela ebalulekile ku-schizophrenia izimpawu ezinhle nezimbi nokukhathazeka, ukucindezeleka, umsebenzi wokuqonda, kuyilapho ukuphepha okuphezulu.Kuphinde kwabikwa ukuthi lesi sidakamizwa singakwazi futhi ukwelapha ezinye izifo zengqondo, njenge-mood disorders manic episodes, i-senile dementia ehambisana nokuphazamiseka kwengqondo, ukuphazamiseka kokukhathazeka, ukuphazamiseka kokuziphatha kwezingane, ukucindezeleka.Namuhla, iBristol-Myers Squibb kanye ne-Otsuka Pharmaceutical Company bamemezele ukuthi i-European Union igunyaze i-Abilify (aripiprazole) ekwelapheni isicelo sokufakwa kuhlu kwe-schizophrenia.

Bhala umyalezo wakho lapha futhi usithumelele wona